cmAngio® vs EchoGo Core
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, cmAngio®, is designed for detecting Breast Arterial Calcifications on mammograms to assess cardiovascular risk, primarily within radiology and OB/GYN workflows. In contrast, Tool B, EchoGo Core, automates the analysis of echocardiograms to provide precise cardiac measurements for diagnosis in cardiology, critical care, and emergency medicine. While both are FDA-cleared AI solutions in the broader cardiology space, they utilize different imaging modalities and address distinct clinical needs, making them adjacent rather than direct competitors.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
cmAngiou00ae by CureMetrix is designed for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment for women. EchoGo Core by Ultromics automates echocardiogram analysis, providing precise measurements for confident cardiac diagnosis, particularly focusing on left ventricular function.
cmAngiou00ae processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams. EchoGo Core is an AI-powered platform that automates the analysis of echocardiograms.
cmAngiou00ae provides AI-based detection and visualization of Breast Arterial Calcifications (BAC) location on a scorecard. EchoGo Core offers automated Left Ventricular (LV) analysis, including measurements for Ejection Fraction (EF), Global Longitudinal Strain (GLS), and LV volumes.
cmAngiou00ae is compatible with any DICOM-compliant viewer. EchoGo Core offers vendor-neutral integration with existing PACS/EHR systems and supports structured reporting.